Drugs / 13C-uracil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01677338 | Jul 2013 → Jun 2014 | dyspepsia | Otsuka Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 13C-uracil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01677338 ↗ |
| Route | Oral | “PO, the Semi-solid Test Meal containing 100 mg of 13C-uracil . Perform the Breath Test.” NCT01677338 ↗ |